Previously, we reported that overexpression of hAR in LDL receptor knockout (Ldlr−/−) (171) and apolipoprotein E null (Apoe−/−)  (172) mice promoted atherosclerosis under hyperglycemic conditions and that pharmacological inhibition of AR reduced lesion size (172). The gene discussed is LYVE1; the disease is atherosclerosis.